MedTrace Logo

Comparison of 3Mixtatin Pulpotomy and Metapex Pulpectomy in Primary Molars With Irreversible Pulpitis

NCT06925490 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-04-27

No results posted yet for this study

Summary

The present study aims to evaluate the clinical and radiographic success of pulpotomy using 3Mixtatin versus pulpectomy using Metapex in primary molars with irreversible pulpitis in children aged 4 to 9 years.

Conditions

  • Irreversible Pulpitis
  • Primary Teeth
  • Pulp Disease, Dental

Interventions

DRUG

Metapex

Pulpectomy using Metapex

DRUG

3Mixtatin

pulpotomy treatment when applying 3mixture of antibiotic (Metronidazole, cefixime, and Ciprofloxacin) along with simvastatin

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Osama Ibrahim El Shahawy, Professor · Professor of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Cairo University

  • Marwa Aly Fouad, Associate professor · Associate Professor of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-30
Primary Completion
2026-09-30
Completion
2026-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06925490 on ClinicalTrials.gov